SNAPC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.718900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.847200E-01
Normal-vs-Stage2
2.624600E-03
Normal-vs-Stage3
2.938200E-01
Normal-vs-Stage4
3.156200E-01
Stage1-vs-Stage2
6.638600E-01
Stage1-vs-Stage3
1.713010E-01
Stage1-vs-Stage4
3.704000E-01
Stage2-vs-Stage3
2.193000E-01
Stage2-vs-Stage4
5.864400E-01
Stage3-vs-Stage4
1.552650E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.541000E-03
Normal-vs-AfricanAmerican
8.792600E-01
Normal-vs-Asian
6.556800E-01
Caucasian-vs-AfricanAmerican
4.632600E-01
Caucasian-vs-Asian
1.442410E-01
AfricanAmerican-vs-Asian
6.855200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.148050E-02
Normal-vs-Female
1.265710E-02
Male-vs-Female
8.501200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.798000E-01
Normal-vs-Age(41-60Yrs)
4.36409999999832E-05
Normal-vs-Age(61-80Yrs)
2.478600E-01
Normal-vs-Age(81-100Yrs)
8.262400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.851200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.863800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.609600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.432700E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.084200E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.789800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.659400E-01
Normal-vs-Daily Drinker
4.320400E-01
Normal-vs-Weekly Drinker
9.000400E-01
Normal-vs-Occasional Drinker
3.145600E-02
Normal-vs-Social Drinker
5.914000E-01
Non Drinker-vs-Daily Drinker
8.536800E-01
Non Drinker-vs-Weekly Drinker
5.425800E-01
Non Drinker-vs-Occasional Drinker
1.025210E-01
Non Drinker-vs-Social Drinker
7.299600E-01
Daily Drinker-vs-Weekly Drinker
6.587600E-01
Daily Drinker-vs-Occasional Drinker
9.883900E-02
Daily Drinker-vs-Social Drinker
8.627000E-01
Weekly Drinker-vs-Occasional Drinker
8.276300E-02
Weekly Drinker-vs-Social Drinker
7.772600E-01
Occasional Drinker-vs-Social Drinker
9.159700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.898200E-01
Normal-vs-Grade 2
8.521200E-01
Normal-vs-Grade 3
5.515000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.893700E-02
Grade 1-vs-Grade 3
2.361600E-02
Grade 1-vs-Grade 4
9.898200E-01
Grade 2-vs-Grade 3
4.938000E-01
Grade 2-vs-Grade 4
8.521200E-01
Grade 3-vs-Grade 4
5.515000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.052990E-01
Normal-vs-NonDiabetic
1.530000E-02
Diabetic-vs-NonDiabetic
8.743000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.033200E-01
Normal-vs-NoPancreatitis
9.203600E-03
Pancreatitis-vs-NoPancreatitis
6.773800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.607600E-01
Normal-vs-N1
1.336130E-03
N0-vs-N1
9.117700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.198800E-01
Normal-vs-TP53-NonMutant
5.642400E-01
TP53-Mutant-vs-TP53-NonMutant
8.820600E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
